The fact that elevated MUC4 expression occurs in the majority (70-80%) of pancreatic carcinomas, most notably at early onset of disease progression, leads to the discussion of MUC4 as a new tumor marker for this deadly disease [47]. This evidence concerns the gene MUC4 and exocrine pancreatic carcinoma.